Premium
Duration of oxaliplatin‐based adjuvant chemotherapy in patients with Stage III or high‐risk Stage II resected colon cancer
Author(s) -
Moretto Roberto,
Falcone Alfredo,
Cremolini Chiara
Publication year - 2020
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.32884
Subject(s) - oxaliplatin , folfox , medicine , capecitabine , colorectal cancer , stage (stratigraphy) , fluorouracil , surgery , oncology , relative risk , chemotherapy , cancer , confidence interval , paleontology , biology